The Patent Finder
ZD

Zevra Denmark A/S

First filing 2011
OverviewNotableFeesChangesFamiliesPatent listSources & methods

14 patents currently held

1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.

The next term ends in Jun 2029. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
7
Ending by 2030
Jun 2029
Next term end
6
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 25, 2027
    The maintenance fee for Processes for Preparing Arimoclomol Citrate and Intermediates Thereof (US 11,707,456) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
  • 2 fees due Jul 14 to 28, 2027 · next Jul 14
  • 2 fees due Sep 22 to 26, 2027 · next Sep 22

Which patents, and when each one lapses · Pro

Recent changes

What they patent

The 5 largest of its 6 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 9,884,058Use of HSP70 as a Regulator of Enzymatic Activity
In force
 · High confidence
In forceHigh confidence
US 11,045,460Use of HSP70 as a Regulator of Enzymatic Activity
In force
 · High confidence
In forceHigh confidence
US 11,304,941Use of HSP70 as a Regulator of Enzymatic Activity
In force
 · High confidence
In forceHigh confidence
US 11,938,125Use of HSP70 as a Regulator of Enzymatic Activity
In force
 · High confidence
In forceHigh confidence
US 8,540,985Use of HSP70 as a Regulator of Enzymatic Activity
In force
 · High confidence
In forceHigh confidence
US 9,289,472Use of HSP70 as a Regulator of Enzymatic Activity
In force
 · High confidence
In forceHigh confidence
US 10,543,204Use of HSP70 as a Regulator of Enzymatic Activity
In force
 · High confidence
In forceHigh confidence
US 9,662,375Methods for Increasing Intracellular Activity of HSP70
In force
 · High confidence
In forceHigh confidence
US 10,532,085Methods for Increasing Intracellular Activity of HSP70
In force
 · Medium confidence
In forceMedium confidence
US 11,229,633Arimoclomol Formulation
In force
 · High confidence
In forceHigh confidence
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
Also on record, not counted in the 14: 1 patent in force now held by others · 9 applications pending · 4 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited